Exchange: OTC·Updated 10:35 AM EDT

VACBF Nykode Therapeutics AS

$0.3542
$0.0329
(10.24%)
Today
EarningsAug 26
Mkt Cap$115.66M
Vol500.00

About VACBF

Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway.
20

Extremely Bearish Sentiment

How do you feel about VACBF?

Advertisement|Remove ads.